Woodline Partners LP Deciphera Pharmaceuticals, Inc. Transaction History

Woodline Partners LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$10.11 - $16.54 $4.01 Million - $6.55 Million	396,239 New	396,239 $6.39 Million
Q1 2023 May 15, 2023	BUY	$14.26 - $22.1 $4.85 Million - $7.51 Million	339,905 New	339,905 $5.25 Million
Q1 2021 May 17, 2021	SELL	$40.39 - $56.73 $1.41 Million - $1.97 Million	-34,797 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$51.77 - $66.18 $1.8 Million - $2.3 Million	34,797 New	34,797 $1.99 Million
Q1 2020 May 15, 2020	SELL	$33.63 - $69.4 $762,055 - $1.57 Million	-22,660 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$31.7 - $69.93 $718,322 - $1.58 Million	22,660 New	22,660 $1.41 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.